Your browser doesn't support javascript.
Particulate multivalent presentation of the receptor binding domain induces protective immune responses against MERS-CoV.
Okba, Nisreen M A; Widjaja, Ivy; van Dieren, Brenda; Aebischer, Andrea; van Amerongen, Geert; de Waal, Leon; Stittelaar, Koert J; Schipper, Debby; Martina, Byron; van den Brand, Judith M A; Beer, Martin; Bosch, Berend-Jan; Haagmans, Bart L.
  • Okba NMA; Department of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Widjaja I; Virology Division, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.
  • van Dieren B; Virology Division, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.
  • Aebischer A; Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Insel Riems, Germany.
  • van Amerongen G; Viroclinics Biosciences BV, Rotterdam, The Netherlands.
  • de Waal L; Viroclinics Biosciences BV, Rotterdam, The Netherlands.
  • Stittelaar KJ; Viroclinics Biosciences BV, Rotterdam, The Netherlands.
  • Schipper D; Department of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Martina B; Department of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands.
  • van den Brand JMA; Department of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Beer M; Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Insel Riems, Germany.
  • Bosch BJ; Virology Division, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.
  • Haagmans BL; Department of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands.
Emerg Microbes Infect ; 9(1): 1080-1091, 2020 Dec.
Article in English | MEDLINE | ID: covidwho-429885
ABSTRACT
Middle East respiratory syndrome coronavirus (MERS-CoV) is a WHO priority pathogen for which vaccines are urgently needed. Using an immune-focusing approach, we created self-assembling particles multivalently displaying critical regions of the MERS-CoV spike protein ─fusion peptide, heptad repeat 2, and receptor binding domain (RBD) ─ and tested their immunogenicity and protective capacity in rabbits. Using a "plug-and-display" SpyTag/SpyCatcher system, we coupled RBD to lumazine synthase (LS) particles producing multimeric RBD-presenting particles (RBD-LS). RBD-LS vaccination induced antibody responses of high magnitude and quality (avidity, MERS-CoV neutralizing capacity, and mucosal immunity) with cross-clade neutralization. The antibody responses were associated with blocking viral replication and upper and lower respiratory tract protection against MERS-CoV infection in rabbits. This arrayed multivalent presentation of the viral RBD using the antigen-SpyTag/LS-SpyCatcher is a promising MERS-CoV vaccine candidate and this platform may be applied for the rapid development of vaccines against other emerging viruses such as SARS-CoV-2.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Viral Vaccines / Coronavirus Infections / Antigen Presentation / Spike Glycoprotein, Coronavirus / Antibody Formation Type of study: Randomized controlled trials Topics: Vaccines Limits: Animals / Female / Humans Language: English Journal: Emerg Microbes Infect Year: 2020 Document Type: Article Affiliation country: 22221751.2020.1760735

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Viral Vaccines / Coronavirus Infections / Antigen Presentation / Spike Glycoprotein, Coronavirus / Antibody Formation Type of study: Randomized controlled trials Topics: Vaccines Limits: Animals / Female / Humans Language: English Journal: Emerg Microbes Infect Year: 2020 Document Type: Article Affiliation country: 22221751.2020.1760735